Christopher Bridgeman

Trainee Biomedical Scientist
Cambridge University Hospitals NHS Foundation Trust

Presentation(s):

• PB0052 - Assessing Endothelial Activation and Risk of Bleeding in patients receiving VV-ECMO supportive therapy for COVID-19 using non-standard laboratory assays

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0600 - ADAMTS13 activity and non-parallel vWF Ristocetin CoFactor activity are associated with severity of COVID-19 infection

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1068 - Dilute Thrombin Time versus activated Partial thromboplastin Time to monitor Argatroban in critically ill patients.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM